MedTrace Logo

Acotiamide vs Itopride in Postprandial Distress Syndrome

NCT07174297 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2025-09-23

No results posted yet for this study

Summary

The goal of this study is to "To compare the efficacy and safety of Acotiamide versus Itopride in patient with post prandial distress syndrome type of functional dyspepsia"

Conditions

  • Postprandial Distress Syndrome

Interventions

DRUG

Acotiamide

Both these drugs are used for the management of PDS type of FD

Sponsors & Collaborators

  • Rawalpindi Medical College, Pakistan

    collaborator OTHER

  • Getz Pharma

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. Muahmmad Umar, MBBS, FCPS, FACG, AGAF, FRCP · Rawalpindi Medical University/College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-30
Primary Completion
2026-12-30
Completion
2027-04-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07174297 on ClinicalTrials.gov